NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $507,180 | -46.7% | 474,000 | +29.0% | 0.00% | -50.0% |
Q2 2023 | $951,566 | -36.8% | 367,400 | -0.4% | 0.00% | -50.0% |
Q1 2023 | $1,504,704 | -9.0% | 368,800 | +11.9% | 0.00% | -20.0% |
Q4 2022 | $1,654,090 | -55.9% | 329,500 | +14.9% | 0.01% | -54.5% |
Q3 2022 | $3,750,000 | +48.5% | 286,700 | +45.5% | 0.01% | +57.1% |
Q2 2022 | $2,526,000 | -14.8% | 197,000 | +1.3% | 0.01% | -12.5% |
Q1 2022 | $2,965,000 | -37.2% | 194,400 | -27.1% | 0.01% | -33.3% |
Q4 2021 | $4,725,000 | +35.6% | 266,800 | +60.9% | 0.01% | +33.3% |
Q3 2021 | $3,485,000 | +417.1% | 165,800 | +384.8% | 0.01% | +350.0% |
Q2 2021 | $674,000 | -14.5% | 34,200 | +26.2% | 0.00% | 0.0% |
Q1 2021 | $788,000 | – | 27,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |